During COVID-19 outbreak,

340B Hospitals Ask CMS To Suspend Cuts, Drug Cost Survey

By Michelle M. Stein / March 25, 2020 at 2:07 PM
340B hospitals are asking CMS to use its regulatory flexibility to delay a proposed Medicare survey of 340B hospitals’ drug acquisition costs and to suspend a controversial Part B pay cut for 340B drugs during the COVID-19 pandemic, among other steps. CMS cut Medicare pay for 340B drugs by almost 30% starting in 2018, but a district court said that move went beyond the agency’s authority. CMS said in a February notice that in the event the United States District...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.